Skip to main navigation
Skip to search
Skip to main content
University of Haifa Home
Update your profile
!!Link opens in a new tab
!!Search content at University of Haifa
Home
Researchers
Research units
Research output
Phosphatidylinositol-3-kinase as a therapeutic target in melanoma
Saadia A. Aziz
, Michael Davies
,
Elah Pick
, Christopher Zito
, Lucia Jilaveanu
, Robert L. Camp
, David L. Rimm
, Yuval Kluger
, Harriet M. Kluger
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Phosphatidylinositol-3-kinase as a therapeutic target in melanoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Therapeutic Target
100%
Phosphoinositide 3-kinase (PI3K)
100%
LY294002
100%
Melanoma
100%
P110
66%
Nevus
50%
Phosphatidylinositol 3-kinase Inhibitor
50%
Phosphatidylinositol 3-kinase Pathway
50%
Phospho-Akt
50%
Clinical Trials
16%
Drug Target
16%
IC50
16%
Response Predictors
16%
Kinase Inhibition
16%
Melanoma Patients
16%
Melanoma Cells
16%
Clinical Development
16%
In Vitro Response
16%
Automated Quantitative Analysis
16%
Primary Melanoma
16%
Resistant Cell Lines
16%
Reverse Phase Protein Array
16%
Cellular Process
16%
Phosphatidylinositol 3-kinase/Akt
16%
Medicine and Dentistry
Phosphoinositide 3-Kinase
100%
Melanoma
100%
Therapeutic Target
100%
LY294002
66%
Phosphoinositide 3-Kinase Inhibitor
33%
Nevus
33%
Protein Kinase B
33%
Clinical Trial
11%
In Vitro
11%
Student T Test
11%
Cell Line
11%
Melanoma Cell Line
11%
Protein Microarray
11%
IC50
11%
Resistant Cell Line
11%